William Blair Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-490,968
| Closed | -$40.6M | – | 407 |
|
2022
Q3 | $40.6M | Sell |
490,968
-12,154
| -2% | -$1M | 0.16% | 131 |
|
2022
Q2 | $47.8M | Sell |
503,122
-29,116
| -5% | -$2.77M | 0.18% | 133 |
|
2022
Q1 | $62.7M | Buy |
532,238
+14,279
| +3% | +$1.68M | 0.19% | 140 |
|
2021
Q4 | $67.1M | Buy |
517,959
+62,183
| +14% | +$8.06M | 0.18% | 136 |
|
2021
Q3 | $51.6M | Sell |
455,776
-4,484
| -1% | -$508K | 0.15% | 157 |
|
2021
Q2 | $47.7M | Sell |
460,260
-3,896
| -0.8% | -$404K | 0.15% | 152 |
|
2021
Q1 | $38.8M | Buy |
464,156
+4,469
| +1% | +$374K | 0.13% | 162 |
|
2020
Q4 | $41.9M | Sell |
459,687
-70,919
| -13% | -$6.47M | 0.14% | 145 |
|
2020
Q3 | $42.4M | Sell |
530,606
-62,808
| -11% | -$5.01M | 0.17% | 134 |
|
2020
Q2 | $41M | Sell |
593,414
-101,635
| -15% | -$7.02M | 0.17% | 136 |
|
2020
Q1 | $43.7M | Buy |
695,049
+15,036
| +2% | +$945K | 0.21% | 120 |
|
2019
Q4 | $52.9M | Buy |
+680,013
| New | +$52.9M | 0.21% | 121 |
|
2017
Q4 | – | Sell |
-478,386
| Closed | -$17.4M | – | 439 |
|
2017
Q3 | $17.4M | Sell |
478,386
-6,558
| -1% | -$239K | 0.06% | 276 |
|
2017
Q2 | $19.1M | Sell |
484,944
-149,148
| -24% | -$5.88M | 0.07% | 252 |
|
2017
Q1 | $19.9M | Sell |
634,092
-1,272,360
| -67% | -$39.9M | 0.08% | 247 |
|
2016
Q4 | $59.5M | Buy |
1,906,452
+977,898
| +105% | +$30.5M | 0.24% | 131 |
|
2016
Q3 | $37.3M | Sell |
928,554
-22,317
| -2% | -$897K | 0.14% | 168 |
|
2016
Q2 | $31.6M | Buy |
950,871
+390,078
| +70% | +$13M | 0.13% | 174 |
|
2016
Q1 | $16.5M | Buy |
+560,793
| New | +$16.5M | 0.07% | 237 |
|